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Proton beam therapy offers unique physical properties with potential for reduced 
toxicity and better patient care. There is an increased interest in radiation oncology 
centers to acquire proton therapy capabilities. The operation of a proton treatment 
center is quite different than a photon-based clinic because of the more complex 
technology involved, as well as the single proton beam source serving multiple 
treatment rooms with no backup source available. There is limited published data 
which investigates metrics that can be used to determine the performance of a 
proton facility. The purpose of this study is to evaluate performance metrics of 
Indiana University Cyclotron Operations (IUCO), including availability, mean 
time between failures, and mean time to repair, and to determine how changes in 
these metrics impact patient treatments. We utilized a computerized maintenance 
management system to log all downtime occurrences and servicing operations 
for the facility.  These data were then used to calculate the availability as well as 
the mean time between failures and mean time to repair. Impact on patient treat-
ments was determined by analyzing delayed and missed treatments, which were 
recorded in an electronic medical record and database maintained by the therapists.  
The availability of the IUCO proton beam has been increasing since beginning 
of operation in 2003 and averaged 96.9% for 2009 through 2011. The mean time 
between failures and mean time to repair were also determined and correlated with 
improvements in the maintenance and operating procedures of the facility, as well 
as environmental factors. It was found that events less than 15 minutes in duration 
have minimal impact on treatment delays, while events lasting longer than one 
hour may result in missed treatments. The availability of the proton beam was 
more closely correlated with delayed than with missed treatments, demonstrating 
the utility and limitations of the availability metric. In conclusion, we suggest that 
the availability metric and other performance parameters, such as the mean time 
between failures and the mean time to repair, should be used in combination with 
downtime impact on patient treatments in order to adequately evaluate the opera-
tional success of a proton therapy facility.  
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I. IntroductIon
Proton beam therapy provides a unique opportunity for better patient care by delivering uniform 
dose to the tumor with minimal integral dose to the body, thus possibly reducing complications 
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associated with radiation treatments.(1,2) There has been a recent rush for radiation oncol-
ogy centers to acquire particle beam therapy capabilities; however, the technology is much 
more complex.  
Running a photon clinic is fairly straightforward. Most centers have more than one linear 
accelerator (linac), so if one becomes nonfunctional, patients can be moved to another unit, and 
treatment is unaffected. Short of catastrophic loss (e.g., wave guides, target, klystron, magne-
tron), linac maintenance contracts allow for rapid repair in most localities.  Many centers have 
repair personnel on staff or are covered by the larger maintenance teams of accelerator vendors 
for an annual maintenance fee. The uptime of even linear accelerator-based oncology depart-
ments is within a wide range from 92%–98%.(3,4)  Dawson and Gribble(4) showed that in-house 
engineering staff could improve uptime from 92% to 97.2% for a simple 6 MV beam. Despite 
the increasing complexity of modern accelerators with multileaf collimators, on-board imaging, 
variable dose rate (100-800 MU/min) and high degree of mechanical precision as required by 
TG-142,(5) the technology is sufficiently reliable that the uptime of modern machines is specu-
lated to be up to 98% and decreasing to as low as 84% for installations over 10 years old.(6,7) 
Preventive maintenance (PM) on linacs is well defined and based on years of experience with 
hundreds or thousands of identical units in the field. Because of technological advances, health 
organizations are motivated to replace linacs long before the end of their useful life.  
Cyclotron or synchrotron-based proton treatment centers are a stark contrast to linac-based 
clinics. The PM plan is of enormous importance because the useful life of these units is antici-
pated to be several decades. Operating a proton center requires a thorough weekly PM plan 
backed by highly trained service personnel with a comprehensive supply of spare parts. In no 
case in the United States does a colocated backup unit exist should the primary fail. Further, 
simply moving patients from one treatment room to another is only possible if the problem 
is downstream of the beam delivery system. Given the technology involved and lack of a 
backup unit for the accelerator, the schedule for the clinic’s entire case load could be impacted 
catastrophically. If the beam is restored in a timely fashion, it can simply be a scheduling in-
convenience for the patients and staff as treatments can continue later into the evening. In the 
worst case scenario, treatments are missed, which adversely impacts the patients scheduled to 
be treated and also new patients waiting to begin their treatment course.  
One metric that proton therapy centers use to determine performance and efficiency of their 
treatment facilities is beam availability (Av).
(8) Av is broadly defined as the fraction of time the 
treatment room is online and can be used to treat patients. Av is frequently used as a standard 
metric compared across institutions. However, centers vary in calculating Av. In a recent study 
from Suzuki et al.,(8) only events resulting in treatment breaks longer than 15 minutes were 
included as part of the downtime calculation. Suzuki et al. reported an average yearly Av of 
97% from June 2007 to August 2010 for the MD Anderson Proton Therapy Center. Loma 
Linda University Medical Center (LLUMC) calculated Av in a different manner.
(9) The uptime 
and, thus, the Av was based on the number of treatments missed due to equipment failure, not 
accounting for the actual length of time that the facility can be used to deliver treatments. In 
2009, LLUMC reported an average Av of 98.8%.
(9)
Limited data on beam Av have been reported for cyclotron or synchrotron-based particle 
beam therapy units, possibly due to the limited number of centers. Similarly, to the best of our 
knowledge, there have not been any reports investigating how Av relates to the patient treatment 
schedule. The purpose of this study was to evaluate the Av as well as additional performance 
metrics used at Indiana University Cyclotron Operations (IUCO), the mean time between 
failures (MTBF), and mean time to recovery (MTTR). We also determined how the length of 
downtime events impact patient treatments. Finally, we investigated how Av correlates with 
delayed and missed patient treatments.  
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II. MAtErIALS And MEtHodS
A.  Beam delivery system
IUCO was formerly known as the IU Cyclotron Facility (IUCF). Responsibility for the clinical 
care of patients using the proton beam falls to Indiana University (IU) Health Proton Therapy 
Center (IUHPTC). Responsibility for the design, fabrication, maintenance, and upgrade of 
the IU proton treatment system falls to IUCO, which is a FDA-registered medical device 
manufacturer. IUCO has approximately 30 employees dedicated to operating and servicing the 
proton therapy equipment. There are an additional 35 employees who make up the physics and 
radiation effects research groups, the in-house engineering department that designs upgrades to 
improve reliability and functionality and provides hardware, software, and electronics support 
for the treatment systems, and a machine shop that manufactures all patient-specific devices 
for IUHPTC. The IU proton treatment facility consists of three treatment rooms supplied by a 
common proton accelerator and beam delivery system. One treatment system has a fixed hori-
zontal beam line, while the other two feature a 360° rotating gantry system each with a uniform 
scanning beam nozzle. The 208.4 MeV beam is generated by a sequence of a 750 keV radio 
frequency quadrupole linear accelerator,(10) a 15 MeV cyclotron, and a 208.4 MeV  cyclotron.(11) 
The cyclotrons are operated continuously, delivering beam to a dump which is diverted to 
the treatment rooms or research users on request using a fast (millisecond time scale) kicker 
magnet at the entrance of each room. From the kicker magnet, the proton beam is transported 
to the proton nozzle via an energy selection beam line containing an energy degrader which 
adjusts the proton range between 5 cm and 27 cm (beam energy from 65 MeV to 208.4 MeV). 
Commissioning of the accelerators and fixed horizontal beam room began in 2003, with the 
first patient treatments in April 2004. From 2004 to 2006, only the fixed beam line room was 
available to treat patients. In 2007, the first gantry room went into service and, in 2008, a second 
gantry room was available for treating patients. The beam delivery system has been described 
in more detail previously.(12) 
When the center first opened in 2004, patient treatments were administered for 8 hours per 
day and 5 days per week. When the gantries went into service, the number of patients increased 
and the hours increased to 12 hours per day, 5 days per week. For the past year, the patient 
numbers have continued to increase, and the center is currently treating patients 15 hours per 
day, 5 days per week. Quality assurance testing occurs each morning prior to the start of patient 
treatments, as well as each weeknight after all treatments have been completed. Preventative 
maintenance of the system is performed primarily on weekends.   
B.  Quality metrics
At IUCO/IUHPTC, Av is a measure of the fraction of time all three treatment rooms are avail-
able for scheduled use. Scheduled use includes: patient treatments, research, commissioning of 
new equipment, and any quality assurance testing. We also include any time when the schedule 
is extended due to unforeseen circumstances. Av is represented by Eq. (1).
 Availability = 100 × Uptime/(Uptime + Downtime) (1)
where uptime and downtime are summed for all three treatment rooms. Downtime includes any 
interruptions where the proton beam is requested for research, testing, or treatment, but cannot 
be delivered regardless of the cause.  
Other metrics used by IUCO are the MTBF and the MTTR. The MTBF is a time function 
of the reliability of the system and represents the average time between events which cause 
downtime of the system. The MTTR is the average time required to restore equipment to ser-
vice after a downtime event has occurred. It includes time to diagnose the problem, perform 
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the necessary repair or replacement, perform quality checks, and finally validate the system so 
that patient treatments may continue.
c.  data acquisition
IUCO utilizes a computerized maintenance management system (CMMS) to log all servicing 
operations such as preventive maintenance, improvements and upgrades, and any unscheduled or 
emergency servicing actions. Failures of equipment and abnormal operating events are captured 
in a nonconformance reporting system, tracked and analyzed by IUCO servicing and engineering 
staff. Independent of the CMMS, Proton Therapy System operation is captured in an electronic 
logbook and is used to identify time and duration of all events impacting the schedule and clinic 
use of the beam. All downtime occurrences are logged regardless of their duration. For each 
downtime event, IUHPTC monitors and records the number of patients whose treatments were 
impacted using both an Excel (Microsoft Corp., Redmond, WA) spreadsheet and Multi-ACCESS 
software (IMPAC Medical Systems, Inc., Mountain View, CA). We define impacted treatments 
as: 1) patients whose treatment was delayed but still delivered on the planned day of treatment; 
2) patients whose treatment was missed as a result of the downtime event.  
The annual Av, as well as the MTBF and MTTR reported in this article (Figs. 1-3), were 
determined using data obtained by CMMS from calendar years 2003 to 2011. The relation-
ship between the number and duration of downtime events and patient treatments (Fig. 4), as 
well as the percentage of missed and delayed treatments per month and monthly Av (Fig. 5), 
was determined by correlating the event log from CMMS with the patient log maintained by 
IUHPTC for the 2011 calendar year. The same method was used to determine the correlation 
between Av and patient treatments (Fig. 6) for the time period between January 2010 and 
 December 2011.    
 
Fig. 1. Availability for calendar year 2003 to 2011. Data points correspond to overall availability ( ), availability for the 
treatment room systems from the kicker magnet through the nozzle and patient positioning system ( ), the cyclotron and 
beamlines alone ( ), and external issues ( ) which includes downtime related to power failures, weather related events, 
user errors, and failure of the X-ray system. 
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Fig. 2. Mean time between failures (MTBF) from 2003 to 2011. Data points correspond to the overall system ( ), the treat-
ment room systems ( ), the cyclotron ( ), and external issues ( ) such as power failures and weather related events.
Fig. 3. Mean time to recovery (MTTR) from 2003 to 2011. Data points correspond to the overall system ( ), the treatment 
room systems ( ), the cyclotron ( ), and external issues ( ) such as power failures and weather related events.
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Fig. 4. The number of downtime events and the corresponding percentage of those events which caused treatment delays 
(a) and missed treatments (b) stratified by the length of the downtime event for calendar year 2011. The number of events 
is indicated by the gray bars and includes all events where any component of the system was down. The percentage of 
those events which had an impact on patient treatments is indicated by the black bars.  
(a)
(b)
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Fig. 5. The percentage of treatments (a) which were delayed by month for calendar year 2011 (the data is separated into 
pediatric treatments shown in black and adult treatments shown in gray); the percentage of missed treatments (b) by month 
for calendar year 2011; and the monthly overall availability (c) for calendar year 2011.  
(a)
(b)
(c)
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Fig. 6. The percentage of treatments delayed (a), the percentage of treatments missed (b), and the percentage of patients 
impacted (missed or delayed treatment) (c) are plotted as a function of the overall availability for each month from January 
2010 through December 2011. The line fitted to the data was obtained using least squares linear regression.  
(a)
(b)
(c)
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III. rESuLtS 
A.  Availability 
The Av since proton beam operation began in 2003 is shown in Fig. 1. The Av related strictly 
to the treatment room systems alone has averaged at approximately 99% since startup in 2003. 
The contribution to downtime from external factors is mainly driven by weather and power 
failure events and fluctuates between 0.5% and 2% each year since 2004. The Av of the cyclotron 
systems has remained above 95% since 2008 and its contribution to downtime has recently 
stabilized to 1%–2% each year. This increase in cyclotron and, thus, overall Av, is evidenced by 
an improvement in the MTBF and MTTR, which can be attributed to redesigning or replacing 
unreliable accelerator equipment, changes in maintenance and operating procedures, stocking 
critical spare parts, and improving technical skill levels in our staff.  
A measure of PM and operating procedures is illustrated by the MTBF shown in Fig. 2.  Most 
maintenance and accelerator shutdowns occur on weekends when major pieces of equipment are 
turned off, causing stress on the equipment. Thus, an average of 5 to 10 days between failures 
for accelerator hardware as seen in the cyclotron curve in Fig. 2 is directly related to weekend 
maintenance. The increase in MTBF in 2010 for the cyclotron curve is a result of modifications 
of the system in 2009 to increase reliability. Another cause of accelerator failures is related to 
power quality events, which cause stress on the equipment and increase failure rates. There 
were numerous issues with electrical power in 2011, as seen by the drop in the curve represent-
ing external issues including power failures. The MTBF corresponding to issues with power 
failures is directly related to local weather patterns with numerous episodes of severe weather 
occurring in 2011. For the treatment room systems, the sudden drop in MTBF in 2004 was 
due to the initiation of patient treatments. It has steadily decreased from 2005 to 2009 corre-
sponding to the transition from the single fixed beam line room to two gantry treatment rooms 
and keeping pace with the increase in number of patients being treated. With more machinery 
and increased complexity, issues occurred more often during this time period. Since 2009, the 
MTBF for the treatment room systems has been slowly improving, due to design changes of 
equipment that began to fail due to heavy use.  
Figure 3 shows the MTTR, which is an indicator of how quickly the system can be brought 
back online to resume patient treatments. The MTTR for the cyclotron has decreased since 2003 
due to the redesign of critical components so that they are easier to repair and an improving 
PM program that detects issues before they become catastrophic failures.(13) There has also 
been improvement in restoring the system to operation after a power failure. The MTTR for 
the treatment room systems has remained fairly constant over the past several years, remaining 
between 1 and 2 hours despite steadily increasing use of the equipment. The slight increase 
from 2010 to 2011 for all four curves corresponds to severe power failures in May 2011 that 
required a longer recovery time.  
B.  Patient impact  
The success of day-to-day operation of a proton therapy center can also be judged by the patient 
impact of unscheduled events and downtime. We evaluated the percentage of days per month 
in calendar year 2011 where treatments were either delayed or missed due to downtime events. 
Treatments were affected due to downtime an average of 27.5% of the days or a little less than 
once every three days. In months with bad weather, such as May 2011, patients were impacted 
nearly every day. In January 2011, the treatment schedule was impacted only twice.       
While delays of several hours can be catastrophic for the clinic and result in missed treatments, 
frequent 10-minute delays can also be troublesome, particularly if no extra time is scheduled 
between patients. Figure 4 shows the distribution of all events sorted by length of downtime 
for calendar year 2011 separated into the percentage of events causing delayed treatments 
(a) and missed treatments (b). The majority of events were less than 15 minutes and between 
15 and 30 minutes in length. The category representing events lasting longer than 4 hours was 
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the smallest. To determine the impact of the length of the downtime event on patient treatments, 
each downtime event was correlated with the clinical database to determine if treatments were 
delayed or missed due to the event. As seen in Fig. 4(a), longer downtime events are more likely 
to delay patient treatments. Fewer than 5% of events lasting less than 15 minutes delayed patient 
treatments. In every other category, patient treatments were delayed at least 25% of the time. 
Events that last less than 15 minutes do not result in treatment delays because the majority of 
these events go unnoticed by the clinic. For example, many of the short cyclotron downtime 
events occur between patient treatments or when beam is not required and will have no effect 
on the patient schedule. Whether or not a downtime event results in a delay also depends on 
other factors including which piece of equipment is affected and how much time is scheduled 
for each treatment. Events lasting longer than 4 hours resulted in delayed treatments in nearly 
80% of cases. Less than 100% of treatments are affected by such a lengthy delay because some 
of the downtime events occurred during quality assurance time and not when patients were 
being treated. These data demonstrate that shorter events can be overcome relatively easily, 
while longer events are more likely to result in treatment delays. Figure 4(b) demonstrates that 
events less than 60 minutes in duration are not likely to cause missed treatments, in contrast 
to events lasting longer than one hour where treatments are missed. This result indicates that 
events lasting longer than one hour are the threshold for moving from treatment delays to missed 
fractions in a patient’s course of treatment. 
To determine how Av impacts patient treatments, we correlated both delayed and missed 
treatments with the monthly Av for the 2011 calendar year (Fig. 5). Figure 5(a) shows the 
percentage of treatments which were delayed stratified into adult and pediatric treatments, 
respectively. Because of the high priority placed on the pediatric population, the percentage of 
delayed pediatric treatments was much less than the adult patients with the pediatric treatments 
representing less than 3% of rescheduled treatments for all months of the 2011 calendar year. 
The months with the most pediatric treatment delays were April, May, and July. During May 
and July, there were an increased number of weather events including power outages and days 
during which very high temperature and humidity combined exceeded the facility’s cooling 
capacity and resulted in a correspondingly large number of treatment delays for both adult and 
pediatric patients.  The increased percentage of delayed pediatric treatments observed in April 
corresponds to several power outages which occurred during the morning treatment sessions. 
Figure 5(b) shows the percentage of treatments missed during the 2011 calendar year. Similar 
to Fig. 5(a), May and July had the largest number of missed treatments due to weather events. 
There were also an increased number of missed treatments observed in February and Decem-
ber. The missed treatments observed in February were due to several cyclotron-related issues 
that occurred during the afternoon treatment sessions and resulted in patient treatments being 
cancelled for the rest of the day. The increase in December corresponds to one major cyclotron 
event that resulted in no treatments being administered for that day. The overall Av for each 
month of the 2011 calendar year is shown in Fig. 5(c). May and July had the lowest Av for the 
year, 88% and 91%, respectively, corresponding to the increased weather events during those 
months. During the rest of the year, the overall Av was 95% or above.    
The relationship between Av and impact on patient treatments is plotted for the months 
of January 2010 through December 2011 in Figs. 6(a)-6(c). The treatments impacted metric 
includes both delayed and missed treatments and is more closely correlated with Av for each 
month (Fig. 6(c)) compared to the delayed or missed treatments individually shown in Figs. 
6(a) and 6(b), respectively. Figure 6(b) demonstrates that with 98% Av, it is anticipated that less 
than 1% of treatments will be missed. As the Av drops to below 96%, there is a broader range 
in percentage of missed treatments. For example, at an Av of 96%, one of the data points has 
fewer than 1% of missed treatments representing August 2011, while at 95% Av, one of the data 
points represents nearly 4% missed treatments for February 2011. Note also that the number 
of missed treatments can be reduced to near zero even though Av is less than 100% because 
treatment delays are likely to occur before treatments are missed in the majority of downtime 
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events. This is demonstrated by the data points clustered around 98% Av. In Fig. 6(b) there 
are several data points corresponding to 0% missed treatments, but in Fig. 6(a) the data points 
corresponding to treatment delays range from 3% to 8%.    
 
IV. dIScuSSIon
Based on the definition of Av in Eq. (1), the overall Av at IUCO for the 2011 calendar year was 
96.1%, with an average of 96.9% over the last three years. MD Anderson reported a three-year 
average of 97%, while LLUMC, using their “treatments missed” method, reported 98.8% in 
2009.(8,9) Suzuki et al.(8) calculated Av in a similar manner to the method reported here, with 
the exception that downtime was defined as any treatment break that lasted 15 minutes or lon-
ger. For our calculation of Av, all downtime events were included, regardless of their duration. 
Our analysis demonstrates that delays less than 15 minutes in duration are negligible and are 
unlikely to cause delayed or missed treatments. Thus, excluding these minor events appears 
to be appropriate when calculating Av. Our original hypothesis was that frequent 10-minute 
delays would compound throughout the day, since there is no extra time scheduled between 
patients. Frequently, a 10-minute delay can propagate into a longer delay if the patient must 
be repositioned. At our facility, this is left to the discretion of the therapist. Some patients will 
need to be reimaged if the break is as little as 2–3 minutes, while anesthesia patients are gener-
ally reimaged only if the treatment delay is longer than 5 minutes. Despite there being no extra 
time scheduled between patients, time can be saved during prostate cancer treatments. Prostate 
cases can routinely be delivered in less time than what is allotted, leaving 5–10 minutes of 
extra time that can be used as “make-up” time for more complex cases. While shorter delay 
times can be an inconvenience, longer delays are more catastrophic to the patient schedule, 
based on our data.
The Av reported from LLUMC bases downtime on the fraction of missed treatments.  Using 
this method, the average Av for 2011 for IUCO was calculated to be 98.3%, compared to 96.1% 
when calculated using Eq. (1). Of note, during May 2011 which had an Av of less than 88% based 
on Eq. (1), the Av using the LLUMC method was 95%. While this method is useful for quan-
tifying the number of missed treatments, it does not reflect the fraction of time that the system 
is online and, thus, does not adequately reflect treatment delays.  During May 2011, more than 
40% of the days had downtime events where treatments were either delayed or missed. Thus, 
both the staff and patients were greatly inconvenienced, but the Av remained above 95% for the 
month when the calculation was performed based on the number of missed treatments.  
One of the limitations of the definition of Av used in this study is the inclusion of scheduled 
beam use not directly involved with patient treatments. Ideally, to correlate Av with missed and 
delayed treatments, only scheduled beam use involving patient treatments should be included. 
However, Av during quality assurance testing is the same as during treatments, since operation 
and repair of the equipment is treated with the same urgency.  Commissioning of new equipment 
and research represents less than 1% of the total time the equipment is in use and so contributes 
very little to the overall Av. As a result, the decision was made to include all scheduled use in 
the definition of Av used for this study.  
Investigating the data that we have collected on patient treatments and correlating with 
the Av of our facility have made us recognize the limitations of Av as a performance metric, 
particularly for patient treatments. The Av correlates better with treatment delays than it does 
with missed treatments, as shown in Figs. 6(a) and 6(b). The percentage of missed treatments 
is highly dependent on the duration of the failures causing the decrease in Av. Fewer treatments 
are missed if downtime events are frequent but of short duration. More treatments are missed 
in the event of shutdowns greater than four hours even though the impact on Av will not be as 
great. This is illustrated by the data in Fig. 5. There was one day during the month of Decem-
ber when the cyclotron was down and no patients could be treated. The Av for December was 
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95.7% and approximately 3% of patient treatments were missed, compared to August which 
had multiple short events during the month and had an Av of 96.1% with 0.4% of treatments 
missed. The percentage of treatment delays was similar for the two months, at approximately 
6%. A similar scenario occurred during February, when there were multiple large cyclotron 
issues on several afternoons of the month, resulting in missed treatments. The Av for Febru-
ary was 95.2%. Based on the data in Figs. 4 and 5, it is likely that a servicing and preventive 
maintenance program that reduces or eliminates the occurrence of failures causing shutdowns 
greater than 1 hour will nearly eliminate missed treatments.  
The Av also does not take into account when the downtime events occur, which can have 
a large impact on patient treatments, particularly in the pediatric population. Many pediatric 
patients require general anesthesia for their treatment and, consequently, are fasting prior to 
their treatment. If a downtime event occurs in the morning, the physician and the family must 
reach an agreement on the treatment for that day. An additional complicating factor is the avail-
ability of the anesthesia team depending on the length of the delay. For the pediatric population, 
treatment delays can easily turn into missed treatments because of the additional complications 
of fasting and general anesthesia for the treatment.   
While the Av is of limited use when assessing the impact of downtime on patient treatments, 
it is also not a stand-alone metric for evaluating the treatment system. While the overall Av can 
be used to determine that there is an issue with the system, additional data must be collected to 
determine what the issue is and how it can be improved. This is accomplished at IUCO using a 
log that contains the root cause of all downtime events. The cyclotron was the major contributor 
to downtime until 2009. After 2009, the external issues related to power failures and weather 
had the greatest impact on Av. This can be verified by the MTBF which shows that while the 
treatment room systems have been stable for the last several years, the main issue for 2011 was 
power failures. The MTTR also reflects this trend with an increase in 2011 due to severe power 
outages. With more power failures, there are more equipment failures as well, particularly with 
the cyclotron, as indicated by the decrease in MTBF in 2011. With this information, PM can be 
focused on the area of the system where it is needed most, such as desensitizing equipment to 
power quality events. Also, by evaluating additional performance metrics such as the MTTR, 
the center can monitor its progress on diagnosing, repairing, and returning the treatment system 
to functional status, and preventing delays lasting longer than one hour to minimize the number 
of treatments that are missed.  
With the shortcomings of Av, it begs the question of whether an ideal metric for assessing 
the performance of a proton therapy center exists. We would argue that a perfect metric does 
not exist and that a combination of metrics must be used to properly capture all aspects of the 
functionality of a treatment facility. Along with the Av of the treatment system, assessment of 
patient treatments must be considered. It is also helpful to investigate the Av of the treatment 
system over a variety of different time durations. Yearly, and even monthly, analysis of Av may 
mask issues with the treatment system that need to be addressed, as demonstrated by the data that 
we present here. For example, if yearly Av data only is analyzed, there may be months during 
the year where the Av is low and a high number of patient treatments are adversely impacted, 
which would not be reflected in the yearly Av metric.    
 
V. concLuSIonS
With the increase in number of proton therapy centers comes the need for developing metrics 
to adequately assess the performance of these facilities. In this article, we demonstrated the 
utility of Av as a metric, but also showed its limitations as a stand-alone metric. We suggest 
that Av data, as well as additional performance metrics such as the MTBF and the MTTR in 
conjunction with patient treatment data, be utilized when evaluating the performance of a 
proton therapy center.     
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